Page 277«..1020..276277278279..290300..»

Geron’s Embryonic Stem Cell Clinical Trial for Spinal Cord Injury

By Dr. Matthew Watson

Dr.

More:
Geron's Embryonic Stem Cell Clinical Trial for Spinal Cord Injury

To Read More: Geron’s Embryonic Stem Cell Clinical Trial for Spinal Cord Injury
categoriaSpinal Cord Stem Cells commentoComments Off on Geron’s Embryonic Stem Cell Clinical Trial for Spinal Cord Injury | dataSeptember 6th, 2011
Read All

Non-controversial Stem Cells: Rationale for Clinical Use: Neil Riordan, Ph.D. – Miami, FL

By Dr. Matthew Watson

Dr. Riordan discussed types of stem cells used in treatments with a focus on adipose and umbilical cord derived stem cells, including their roles in immune system modulation, inflammation reduction and tissue repair:Autoimmune diseases and spinal cord Injury are highlighted. Dr

Read the original post:
Non-controversial Stem Cells: Rationale for Clinical Use: Neil Riordan, Ph.D. - Miami, FL

To Read More: Non-controversial Stem Cells: Rationale for Clinical Use: Neil Riordan, Ph.D. – Miami, FL
categoriaSpinal Cord Stem Cells commentoComments Off on Non-controversial Stem Cells: Rationale for Clinical Use: Neil Riordan, Ph.D. – Miami, FL | dataSeptember 4th, 2011
Read All

Stem Cell Therapy in Cardiac Disease

By Dr. Matthew Watson

How can we harness the power of stem cells to repair the heart or other damaged organs? Dr.

See the original post:
Stem Cell Therapy in Cardiac Disease

To Read More: Stem Cell Therapy in Cardiac Disease
categoriaCardiac Stem Cells commentoComments Off on Stem Cell Therapy in Cardiac Disease | dataSeptember 4th, 2011
Read All

Oral Surgeon utilizes StemSave to preserve stem cells in wisdom teeth to combat cardiac disease

By Dr. Matthew Watson

Dr John Lupori, an oral and maxillofacial surgeon in Steamboat Springs Colorado utilizes the StemSave recovery and cryopreservation service for one of his patients that was having her wisdom teeth removed. Pensack, a former emergency room doctor who now is a psychiatrist, didnt hesitate when he learned he could have his daughter Miriams cells saved.

View original post here:
Oral Surgeon utilizes StemSave to preserve stem cells in wisdom teeth to combat cardiac disease

To Read More: Oral Surgeon utilizes StemSave to preserve stem cells in wisdom teeth to combat cardiac disease
categoriaCardiac Stem Cells commentoComments Off on Oral Surgeon utilizes StemSave to preserve stem cells in wisdom teeth to combat cardiac disease | dataSeptember 4th, 2011
Read All

Coffee, Sex, Smog Can All Trigger Heart Attack, Study Finds

By Dr. Matthew Watson

(HealthDay News) -- A major analysis of data on potential triggers for heart attacks finds that many of the substances and activities Americans indulge in every day -- coffee, alcohol, sex, even breathing -- can all help spur an attack.

Because so many people are exposed to dirty air, air pollution while stuck in traffic topped the list of potential heart attack triggers, with the researchers pegging 7.4 percent of heart attacks to roadway smog.

But coffee was also linked to 5 percent of attacks, booze to another 5 percent, and pot smoking to just under 1 percent, the European researchers found.

Among everyday activities, exerting yourself physically was linked to 6.2 percent of heart attacks, indulging in a heavy meal was estimated to trigger 2.7 percent, and sex was linked to 2.2 percent.

The researchers stressed that the risk for heart attack from any one of these factors to a particular person at any given time is extremely small. But spread out over the population, they can add up.

For example, air pollution is a minor trigger for heart attacks, but since so many people are exposed to smog, it triggers many more heart attacks than other more potent triggers, such as alcohol and cocaine. Read more...

Immunice for Immune Support

Source:
http://feeds.feedburner.com/integratedmedicine

To Read More: Coffee, Sex, Smog Can All Trigger Heart Attack, Study Finds
categoriaIntegrative Medicine commentoComments Off on Coffee, Sex, Smog Can All Trigger Heart Attack, Study Finds | dataSeptember 4th, 2011
Read All

Sims 2 Mafia Story Part 7 – Farewell, Godfather/Stem Cell Medicine

By Dr. Matthew Watson

~ Part 7 ~ Three years have passed since Danielle (Neyla) escaped from the Mafia, and things are going well for her: She lives in the fabulous suburbs of Miami Shores, makes an honest living as a Registered Nurse at the local hospital, makes a lot of money, has lots of friends, is a god-fearing Catholic, and is more stronger, wiser, mature and a whole different person than she once was before. But while things are looking up for Danielle, things are going downhill for the Mafia, as "Godfather" Roscoe Genevieve, falls ill with terminal cancer as a side effect of overdosing on anti-aging drugs, leaving members of the mafia in grief and turnoil, as they all are about to lose someone very dear to them in their small, close-knit family, and are not sure what hand fate will deal them while Roscoe is on his deathbed...... Meanwhile, Danielle, having trouble trying to rest, accidentally stumbles upon a secret scientific discovery in regenerative medicine,as she finds a vial containing an engineered substance called Re-Gen, a chemical agent that uses the application of stem cells and other elements to regenerate any cell in the human body and alter their functions to heal any injury, wound, illness, or dysfunction of any kind in the human body, created by Kenneth, who tells her that he's been keeping it secret from the greedy corporate bigwigs at Empire to prevent them from stealing his research and using it for evil....

Originally posted here:
Sims 2 Mafia Story Part 7 - Farewell, Godfather/Stem Cell Medicine

To Read More: Sims 2 Mafia Story Part 7 – Farewell, Godfather/Stem Cell Medicine
categoriaUncategorized commentoComments Off on Sims 2 Mafia Story Part 7 – Farewell, Godfather/Stem Cell Medicine | dataAugust 30th, 2011
Read All

Reverse Heart Disease without Meds

By Dr. Matthew Watson

Each day the media presents horrific news of death and destruction caused by war, terrorism, and other violence. It virtually ignores a silent but much more deadly enemy . . . heart disease.

More than 1.5 million people will have a heart attack this year, with 1 million deaths resulting from heart attacks (or a death every 30 seconds). When it comes to combating heart disease, most information sources promote drugs and surgery as the only viable defenses. We need to keep in mind that angioplasty and bypass surgery have some significant adverse outcomes, including heart attacks, stroke and death. Most people treated with such interventions continue to suffer from, and eventually die from, heart disease. The average person is not aware that there are safer, more effective options available. Read more...



Cardiofy Heart Care Supplement

Source:
http://feeds.feedburner.com/integratedmedicine

To Read More: Reverse Heart Disease without Meds
categoriaIntegrative Medicine commentoComments Off on Reverse Heart Disease without Meds | dataAugust 28th, 2011
Read All

The nightmare world of ‘trans-humanism’ – WND.com

By Dr. Matthew Watson


WND.com
The nightmare world of 'trans-humanism'
WND.com
You've heard of bio-engineering or genetic engineering. Well, it doesn't just involve crops and animals any more. Now there are active efforts under way to "improve" mankind – even to achieve immortality through science. If you want to get a glimpse of ...

Source:
http://news.google.com/news?q=genetic-engineering&output=rss

To Read More: The nightmare world of ‘trans-humanism’ – WND.com
categoriaUncategorized commentoComments Off on The nightmare world of ‘trans-humanism’ – WND.com | dataAugust 28th, 2011
Read All

Rockets, gunfire and the kindness of strangers – Telegraph.co.uk

By Dr. Matthew Watson


Telegraph.co.uk
Rockets, gunfire and the kindness of strangers
Telegraph.co.uk
His name was Adel Alyaser, 35, a post-graduate student of genetic engineering. After the mayhem outside the flat seemed unreal; pine furniture, thick carpets and a flat-screen television. He supported the revolution – to my relief – and the two ...

Source:
http://news.google.com/news?q=genetic-engineering&output=rss

To Read More: Rockets, gunfire and the kindness of strangers – Telegraph.co.uk
categoriaUncategorized commentoComments Off on Rockets, gunfire and the kindness of strangers – Telegraph.co.uk | dataAugust 28th, 2011
Read All

Generex Biotechnology Corporation (OTC:GNBT): AE37 Update Unable to Move Share … – Market Playground

By Dr. Matthew Watson


Market Playground
Generex Biotechnology Corporation (OTC:GNBT): AE37 Update Unable to Move Share ...
Market Playground
By VFC's Stock House Generex Biotechnology Corporation (OTC:GNBT) subsidiary Antigen Express provided an update on its cancer immunotherapy AE37 last week, but the news – which was the announcement of positive interim results – failed to move the GNBT ...

and more »

Source:
http://news.google.com/news?q=biotechnology&output=rss

To Read More: Generex Biotechnology Corporation (OTC:GNBT): AE37 Update Unable to Move Share … – Market Playground
categoriaUncategorized commentoComments Off on Generex Biotechnology Corporation (OTC:GNBT): AE37 Update Unable to Move Share … – Market Playground | dataAugust 28th, 2011
Read All

San Diego’s Genomatica, a Pioneer in Industrial Biotechnology, Files for IPO – Xconomy

By Dr. Matthew Watson


CNET
San Diego's Genomatica, a Pioneer in Industrial Biotechnology, Files for IPO
Xconomy
The San Diego company, which was founded in 1998, has emerged in recent years as a pioneer in industrial biotechnology. Using a proprietary software technology to model metabolic processes, the company has successfully demonstrated its ability to ...
Green chemicals company Genomatica files for IPOCNET
Genomatica Files For IPOsocalTech.com

all 26 news articles »

Source:
http://news.google.com/news?q=biotechnology&output=rss

To Read More: San Diego’s Genomatica, a Pioneer in Industrial Biotechnology, Files for IPO – Xconomy
categoriaUncategorized commentoComments Off on San Diego’s Genomatica, a Pioneer in Industrial Biotechnology, Files for IPO – Xconomy | dataAugust 28th, 2011
Read All

International Stem Cell Corporation presents "The Promising Cells" Video

By Dr. Matthew Watson

In this video presentation, see and hear an overview of International Stem Cell Corporation (ISCO.OB). ISCO has developed a process to derive stem cells similar to Embryonic Stem Cells without the need for fertilized embryos and with minimal exposure to non-human cells. These factors provide ISC a unique leadership role in the field of regenerative cell therapy. You'll hear directly from Executive Chairman, Kenneth Aldrich. Lifeline Cell Technology and Skin Care Products, revenue generating units of ISCO are also reviewed.


This presentation was produced by Big Sky Productions, INC (BGSI.OB), Co-Executive Producers Ellis Martin and Bob Lange. 

Unfortunately, this content is currently being updated and will be posted again soon.

Source:
http://intlstemcell.blogspot.com/feeds/posts/default?alt=rss

To Read More: International Stem Cell Corporation presents "The Promising Cells" Video
categoriaStem Cell Therapy commentoComments Off on International Stem Cell Corporation presents "The Promising Cells" Video | dataAugust 28th, 2011
Read All

Onemedplace.com Interview – "International Stem Cell Corp Develops Similar Embryonic Stem Cells Without Fertilized Embryos"

By Dr. Matthew Watson

Ken Aldrich, Executive Chairman of International Stem Cell Corporation [OTC:ISCO] was interviewed by OneMedRadio where he discussed the company’s regenerative medicine therapies.
Brett Johnson:  Good day, this is Brett Johnson in New York City with OneMedRadio. Today, I am with Ken Aldrich. He is the co-founder and executive chairman for International Stem Cell, symbol ISCO on the bulletin board. It is a Carlsbad, California company in the stem cell business.  Ken, thanks for joining us today.
Kenneth Aldrich: Thank you. I appreciate the opportunity to speak with you.
BJ: Ken, go ahead and tell us a little bit about the business of International Stem Cell and what you guys are doing that’s unique and distinctive.
KA: I’d be happy to. International Stem Cell is in the regenerative medicine business broadly speaking. We produce and develop therapies that are based on what are called pluripotent stem cells. Pluripotent stem cell simply means a stem cell that can be converted  (the technical word is differentiated) into any cell in the body and theoretically treat any kind of disease that can be treated with cell therapy.
There are today basically only two ways to create a pluripotent stem cell. One is what’s been around for ten years called embryonic stem cells derived from a fertilized human embryo, and the other is parthenogenesis, which is our own creation, our own patent. Our people really developed it from the very beginning.
They function very much the same but we have two unique advantages. One, we take the ethical issue right off the table. We do not use a fertilized egg and we never damage or destroy anything that could become a human being. And second, the DNA that results when we go through that process of using only an unfertilized egg is a much simpler DNA structure. It’s complete, but simpler in its form. It enables us to use a single cell line from a single donor to match very large numbers of people. So it gives us the potential a few years down the road to have a true stem cell bank. And by that I don’t mean the banking of somebody’s own cells, but a bank much like a blood bank in which any patient who needs stem cells can come, get cells that will match their immune system and thereby eliminate or reduce the need for immunosuppressant drugs.
We think ultimately that’s going to be the single defining differentiator for our company because a cell transplant is like a miniature organ transplant. If the body rejects it, there’s no benefit, and we’re working on a way to provide cells that anyone can use at any time for any disease that any scientist is smart enough to figure out a way to treat with cells. It’s a tall order but we think we’re up to it.
To read the full text or listen to the interview, please visit onemedplace -http://www.onemedplace.com/blog/archives/9031

Source:
http://intlstemcell.blogspot.com/feeds/posts/default?alt=rss

To Read More: Onemedplace.com Interview – "International Stem Cell Corp Develops Similar Embryonic Stem Cells Without Fertilized Embryos"
categoriaStem Cell Therapy commentoComments Off on Onemedplace.com Interview – "International Stem Cell Corp Develops Similar Embryonic Stem Cells Without Fertilized Embryos" | dataAugust 28th, 2011
Read All

International Stem Cell Corporation to Present at the Southern California Investor Conference on Monday, August 29th

By Dr. Matthew Watson

International Stem Cell Corporation (OTCBB: ISCO) announced today that Kenneth Aldrich, Chairman, will be presenting at the 2011 Southern California Investor Conference on Monday, August 29, 2011 at 1:30 p.m. Pacific (4:30 p.m. Eastern). The conference takes place at The Island Hotel in Newport Beach, California.


The Southern California Investor Conference is the only conference focused exclusively on the wealth of exciting growth companies from Southern California. The annual one-day conference features more than 35 companies from the region presenting to attendees from throughout the nation. The conference is open to the public and investors can find a list of 2011 presenting companies and registration information at http://www.CaliforniaStocks.com


A webcast of the International Stem Cell Corporation presentation will be accessible online at http://events.powerstream.net/002/00271/20110829_SCIC_T2/ or from the link on the Company's web site at http://www.internationalstemcell.com. An archived version will be available for 30 days.


About International Stem Cell Corporation
International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenic, homozygous stem cell line that can be a source of therapeutic cells with minimal immune rejection after transplantation into hundreds of millions of individuals of differing genders, ages and racial background. This offers the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology, and cell-based skin care products through its subsidiary Lifeline Skin Care. More information is available at http://www.internationalstemcell.com.


To subscribe to receive ongoing corporate communications, please click on the following link:http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0.


International Stem Cell Corporation
Kenneth C Aldrich, Chairman
760-940-6383
kaldrich@intlstemcell.com

or
Lippert/Heilshorn & Associates
Don Markley
310-691-7100
dmarkley@lhai.com

Source:
http://intlstemcell.blogspot.com/feeds/posts/default?alt=rss

To Read More: International Stem Cell Corporation to Present at the Southern California Investor Conference on Monday, August 29th
categoriaStem Cell Therapy commentoComments Off on International Stem Cell Corporation to Present at the Southern California Investor Conference on Monday, August 29th | dataAugust 28th, 2011
Read All

WikiLeaks: Ambassador Warlick: Bulgarian Government Walks Tight Rope on GMOS – Novinite.com

By Dr. Matthew Watson


Novinite.com
WikiLeaks: Ambassador Warlick: Bulgarian Government Walks Tight Rope on GMOS
Novinite.com
(SBU) Summary: A draft law that would bring Bulgaria's current restrictive biotechnology regime into EU compliance has been seized upon by anti-GMO groups. As a result, as a tactical response, the government is proposing, as a supplement to the draft ...

and more »

Source:
http://news.google.com/news?q=biotechnology&output=rss

To Read More: WikiLeaks: Ambassador Warlick: Bulgarian Government Walks Tight Rope on GMOS – Novinite.com
categoriaUncategorized commentoComments Off on WikiLeaks: Ambassador Warlick: Bulgarian Government Walks Tight Rope on GMOS – Novinite.com | dataAugust 28th, 2011
Read All

Cardiac Stem Cells in End-Stage Human Failing Hearts: Are they functional?

By Dr. Matthew Watson

Sunjay Kaushal USA river-valley.tv

More:
Cardiac Stem Cells in End-Stage Human Failing Hearts: Are they functional?

To Read More: Cardiac Stem Cells in End-Stage Human Failing Hearts: Are they functional?
categoriaCardiac Stem Cells commentoComments Off on Cardiac Stem Cells in End-Stage Human Failing Hearts: Are they functional? | dataAugust 25th, 2011
Read All

Vitamin D deficiency unquestionably linked to bone fractures

By Dr. Matthew Watson

Recent research from Scotland reinforces the longstanding medical opinion that vitamin D deficiency leads to a significantly increased risk of bone fractures.

Among people with hip fractures referred to the Scottish fracture liaison service, 98 percent test positive for serious deficiencies in vitamin D. Supplementation with the vitamin, on the other hand, significantly reduces the risk of repeat fractures.

"Taking a supplement can make a difference quite quickly," said Stephen Gallacher, head of the liaison service. "Bone density can increase by 20 percent in a few months with enough vitamin D."

"We have found we can reduce fractures by something like 30 to 50 percent. It is our belief that we can significantly reduce the risk of fractures in the population by giving people anti-osteoporosis therapy and vitamin D supplements."Read more...

Cardiofy Heart Care Supplement

Source:
http://feeds.feedburner.com/integratedmedicine

To Read More: Vitamin D deficiency unquestionably linked to bone fractures
categoriaIntegrative Medicine commentoComments Off on Vitamin D deficiency unquestionably linked to bone fractures | dataAugust 21st, 2011
Read All

The Cleverness Of The Apes (GALLERY) – Global Animal

By Dr. Matthew Watson


The Guardian (blog)
The Cleverness Of The Apes (GALLERY)
Global Animal
(GREAT APES/ANIMAL SCIENCE) In “Rise of the Planet of the Apes,” experiments with genetic engineering lead to an incredibly intelligent species of ape. In reality, these non-human primates are in fact very smart and have better, faster memories than we ...
Movie Review: Rise of the Planet of the ApesWishaw Press
Rise of the Planet of the Apes – 'Human, all too human'The Guardian (blog)

all 118 news articles »

Source:
http://news.google.com/news?q=genetic-engineering&output=rss

To Read More: The Cleverness Of The Apes (GALLERY) – Global Animal
categoriaUncategorized commentoComments Off on The Cleverness Of The Apes (GALLERY) – Global Animal | dataAugust 21st, 2011
Read All

2nd International Festival of Biotechnology – India: – Sunday Observer

By Dr. Matthew Watson


Sunday Observer
2nd International Festival of Biotechnology - India:
Sunday Observer
Nalanda College, Colombo won first place at the 2nd International Festival of Biotechnology held at the CMS Rajendra Nagar Campus - 1 Lucknow, India. Fifty-six schools representing Sri Lanka, India, Bangladesh, Nepal, Bhutan, Pakistan and Russia ...

Source:
http://news.google.com/news?q=biotechnology&output=rss

To Read More: 2nd International Festival of Biotechnology – India: – Sunday Observer
categoriaUncategorized commentoComments Off on 2nd International Festival of Biotechnology – India: – Sunday Observer | dataAugust 21st, 2011
Read All

International Stem Cell’s Q2 Revenues Nearly Triple by Deborah Sterescu

By Dr. Matthew Watson

International Stem Cell Corporation (ISCO) (OTCBB:ISCO) reported Wednesday that second quarter sales more than doubled to almost triple, while year-to-date sales jumped a whopping 271%, as the company's operating subsidiaries continue to generate more revenue.
In addition to its hugely potentially valuable stem cell therapy business, the company also two other operations that have reflected revenue growth in the meantime, including Lifeline Cell Technology, which sells its cell-culture products to researchers to grow human cells for pre-clinical research, and Lifeline Skin Care, which sells skin care products based on its parent's stem cell technology.
For the three months ending June 30, International Stem Cell saw revenues rise to $1.1 million, from $0.44 million a year earlier.
Year-to-date revenues totaled $2.6 million, versus $0.7 million for the same period in 2010, helped by a $1.7 million contribution from Lifeline Skin Care, and a $0.9 million addition from Lifeline Cell.
In the last quarter, Lifeline Cell gained over 200 new customers due to new product introductions and the development of distribution channels internationally, a strategy ISCO plans to continue.
Meanwhile, the company's skin care business is coming off a highly successful launch at the end of last year, exceeding its plans to sell 1,000 products, with 7,000 products sold initially. Lifeline Skin plans to aggressively kick start major marketing initiatives again in September.
While these two subsidiaries are busy chalking up revenues, ISCO, whose parthenogenetic stem cell technology can be used to derive pluripotent stem cells, meaning they can be transformed into any cell type in the body, has many important advantages at its fingertips.
Regenerative medicine is a market that is set to boom in the coming years, as more and more companies are developing therapies based on stem cell use. International Stem Cell's long-term goal is to be a universal supplier of stem cells for not just one, but a host of therapies.
The company's parthenogenetic stem cells are derived from unfertilized eggs, avoiding the ethical issues behind the destruction of viable human embryos. Like embryonic stem cells, they also have the capacity to become almost any cell type in the body, but have demonstrated they are better in terms of the immune system, as one single stem cell line can be genetically matched to millions of people, reducing the need for immunosuppressants.
Its plan is to establish a US bank of its clinical-grade human parthenogenetic stem cells that will be capable of being immune-matched to millions of patients, so that a physician could call up and request a specific cell type for people. The company, which recently received approvals to enroll around 3 US donors for its bank, already has a collection of ten human parthenogenetic stem cell lines used for research purposes, which were derived outside the US.
These cell lines could potentially be used to cure a number of diseases, including cancer, heart disease, liver disease, among many others. Already, the company has several trials in the works, and has successfully demonstrated in pre-clinical animal studies that its stem cells can be used to create viable liver cells. It has also started pre-clinical animal trials to create neuronal cells in the brain, to potentially cure Parkinson's disease.
Unsurprisingly, all this work to progress the company's technology has increased expenses, contributing to a $2.5 million loss in the second quarter, or a 3 cent loss per share.
Research and development costs grew on account of greater scientific projects, while general and administrative costs leapt on increased headcount as the company bulks up its management team.
International Stem Cell, with $3.6 million in the bank at the end of the quarter, said that it has not ruled out future capital raising, but it already has a facility that allows it to draw equity as necessary to secure its planned growth.

Source:
http://intlstemcell.blogspot.com/feeds/posts/default?alt=rss

To Read More: International Stem Cell’s Q2 Revenues Nearly Triple by Deborah Sterescu
categoriaStem Cell Therapy commentoComments Off on International Stem Cell’s Q2 Revenues Nearly Triple by Deborah Sterescu | dataAugust 21st, 2011
Read All

Page 277«..1020..276277278279..290300..»


Copyright :: 2025